Artikler

Beneath the skin of patients with AD—type 2 inflammation and the cytokines involved.

Unpredictable blood glucose readings, extreme fatigue, and an overwhelming fear of low blood glucose—this is how Ingunn describes the early days after her son, Olav, was diagnosed with type 1 diabetes. It has been a time of sleepless nights and many worries. But it has also been a time of learning, adaptation, and strengthened family bonds.

Silje Elfrida (36) lives in Tjodalyng, near Larvik, works in the healthcare sector, and leads a busy life with two very active sons aged seven and five. At the same time, she is navigating an uncertain romantic situation. Diagnosed with type 1 diabetes at the age of 19 in 2007, Silje Elfrida took on the challenge immediately, determined not to let the condition limit her life.

What are the hidden challenges of living with uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)?

As we continue to advance in our understanding and treatment capabilities, our response to uncontrolled AD and PN becomes more effective, paving the way for a future where patients can lead healthier, more comfortable lives⁸.

A clinical consensus statement of Association for acute cardiovascular care (ACVC), in collaboration with European association of preventive cardiology (EAPC) and the European Society of Cardiology working group on cardiovascular Pharmacotherapy Krychtiuk KA, et al. Eur Heart J Acute Cardiovasc Care. 2022;11(12):939–949.

Key principles of lipid management (LDL-C in particular) in accordance with the 2019 ESC/EAS Guidelines for the management of dyslipidaemias, and the 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.

Explore the clinical presentation and pathophysiology of Prurigo Nodularis (PN), including its systemic inflammation, itching-scratching cycle, and effects on quality of life. Learn about the underlying mechanisms and treatment options for this chronic skin condition.

Anti-islet autoantibodies that target proteins associated with beta-cells serve as biomarkers of autoimmune type 1 diabetes (T1D) development.¹ The number of detectable autoantibodies through screening correlates with risk of developing autoimmune T1D.² Assays for detecting autoimmune T1D have shown high sensitivity and specificity.^3,4

Explore the distinct clinical manifestations of Atopic Dermatitis (AD) and Prurigo Nodularis (PN), their impact on patients' lives, and the common thread of type 2 inflammation. Understand how these chronic skin conditions differ and intersect in this comprehensive overview.